Seven Eight Capital, LP Haemonetics Corp Transaction History

Seven Eight Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$84.96 - $118.91 $331,344 - $463,749	-3,900 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$74.34 - $121.82 $240,118 - $393,478	-3,230 Reduced 45.3%	3,900 $389,000
Q4 2019 Feb 13, 2020	BUY	$114.37 - $129.46 $22,874 - $25,892	200 Added 2.89%	7,130 $819,000
Q3 2019 Nov 14, 2019	BUY	$117.16 - $138.52 $811,918 - $959,943	6,930 New	6,930 $874,000
Q4 2018 Feb 14, 2019	SELL	$90.66 - $116.63 $891,187 - $1.15 Million	-9,830 Closed	0 $0
Q3 2018 Oct 18, 2018	SELL	$89.96 - $114.58 $2.23 Million - $2.84 Million	-24,800 Reduced 71.61%	9,830 $1.13 Million
Q2 2018 Aug 07, 2018	SELL	$71.53 - $95.75 $1.59 Million - $2.13 Million	-22,270 Reduced 39.14%	34,630 $3.11 Million
Q1 2018 May 14, 2018	BUY	$60.72 - $74.41 $3.45 Million - $4.23 Million	56,900 New	56,900 $4.16 Million

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.